首页> 外文会议>International Congress of Dermatology >Angiomatoicl fibrous histiocytoma: fact and myth
【24h】

Angiomatoicl fibrous histiocytoma: fact and myth

机译:血管藻纤维组织肌细胞瘤:事实和神话

获取原文

摘要

Angiomatoid fibrous histiocytoma is a diagnosis of considerable confusion for several reasons. First, two different entities hide behind this diagnosis, one a variant of dermatofibromas with prominent hemorrhage, also known as aneurysmal fibrous histiocytoma, the other a low grade malignancy of uncertain differentiation, previously classified among malignant fibrous histiocytoma (MFH) as its angiomatoid variant. Secondly, the concept of MFH itself is problematic and nowadays opinion leaders in soft tissue pathology regard MFH more a reaction pattern than a specific disease. Thirdly, this seems also to be true for atypical fibroxanthoma, the dermal analoge of MFH, which is an important differential diagnosis in this instance. Based on a case of angiomatoid (previously malignant) fibrous histiocytoma I will try to bring some order into this perplexing field of soft tissue pathology.
机译:由于几种原因,血管肌瘤纤维组织细胞瘤是对相当混乱的诊断。首先,两种不同的实体隐藏在这种诊断背后,一种皮肤纤维瘤的一个变种,出血,也称为动脉瘤纤维组织细胞瘤,另一种是低级别的不确定分化恶性肿瘤,以前分类为恶性纤维组织细胞瘤(MFH)作为其血管型变异。其次,MFH本身的概念是有问题的,现在软组织病理学中的意见领导者涉及比特定疾病更高的反应模式。第三,这似乎也适用于非典型纤维体,MFH的皮肤分析,这是这种情况的重要鉴别诊断。基于血管螨(先前恶性的)纤维组织细胞瘤的情况,我将尝试将一些顺序排入这种软组织病理学的令人困惑的领域。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号